Demars Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.94M Buy
5,137
+359
+8% +$424K 1.55% 12
2026
Q2
$5.73M Buy
4,778
+4,288
+875% +$4.38M 1.59% 12
2026
Q1
$451K Buy
490
+15
+3% +$15.2K 0.15% 71
2025
Q4
$511K Sell
475
-88
-16% -$84.1K 0.17% 58
2025
Q3
$429K Sell
563
-194
-26% -$144K 0.15% 65
2025
Q2
$590K Buy
757
+7
+0.9% +$5.44K 0.23% 46
2025
Q1
$620K Buy
750
+78
+12% +$64.9K 0.26% 38
2024
Q4
$519K Hold
672
– – 0.23% 50
2024
Q3
$595K Buy
672
+3
+0.4% +$2.7K 0.27% 36
2024
Q2
$606K Sell
669
-88
-12% -$70.4K 0.29% 35
2024
Q1
$589K Buy
757
+179
+31% +$127K 0.29% 38
2023
Q4
$337K Hold
578
– – 0.18% 51
2023
Q3
$311K Hold
578
– – 0.18% 63
2023
Q2
$271K Buy
+578
New +$242K 0.15% 66

Other funds holding LLY

Demars Financial Group's LLY Position: Q3 2026 in Review

Demars Financial Group increased its Eli Lilly (LLY) stake by 7.5% in Q3 2026, buying an estimated $424K and bringing the position to 5,137 shares worth $5.94M. The position accounts for 1.55% of the portfolio, ranked #12.

Demars Financial Group first reported a position in LLY in Q2 2023 and has held it in 14 quarters since. 3,388 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Demars Financial Group held 5,137 shares of Eli Lilly worth $5.94M as of Q3 2026.
  • Demars Financial Group bought 359 Eli Lilly shares in Q3 2026, an estimated $424K.
  • Eli Lilly made up 1.55% of Demars Financial Group's portfolio in Q3 2026, its #12 holding.
  • Demars Financial Group first reported a position in Eli Lilly in Q2 2023 and has held it in 14 quarters since.
  • 3,388 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Demars Financial Group's 13F filing for Q3 2026, filed 22 Oct 2026.